ATE367808T1 - N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren - Google Patents

N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren

Info

Publication number
ATE367808T1
ATE367808T1 AT96910804T AT96910804T ATE367808T1 AT E367808 T1 ATE367808 T1 AT E367808T1 AT 96910804 T AT96910804 T AT 96910804T AT 96910804 T AT96910804 T AT 96910804T AT E367808 T1 ATE367808 T1 AT E367808T1
Authority
AT
Austria
Prior art keywords
growth
chlorphenylthiocarbamates
chlorphenyl
viruses
inhibiting
Prior art date
Application number
AT96910804T
Other languages
English (en)
Inventor
James Camden
Original Assignee
Uaf Technologies And Res Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/420,913 external-priority patent/US5629341A/en
Application filed by Uaf Technologies And Res Llc filed Critical Uaf Technologies And Res Llc
Application granted granted Critical
Publication of ATE367808T1 publication Critical patent/ATE367808T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96910804T 1995-04-12 1996-04-11 N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren ATE367808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/420,913 US5629341A (en) 1995-04-12 1995-04-12 Pharmaceutical composition for inhibiting the growth of viruses and cancers
US188895P 1995-08-04 1995-08-04

Publications (1)

Publication Number Publication Date
ATE367808T1 true ATE367808T1 (de) 2007-08-15

Family

ID=26669618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96910804T ATE367808T1 (de) 1995-04-12 1996-04-11 N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren

Country Status (21)

Country Link
US (3) US5932604A (de)
EP (1) EP0820281B1 (de)
JP (1) JPH11503460A (de)
KR (1) KR19980703829A (de)
CN (1) CN1181701A (de)
AT (1) ATE367808T1 (de)
AU (1) AU714056B2 (de)
BR (1) BR9604973A (de)
CA (1) CA2217953C (de)
CZ (1) CZ323597A3 (de)
DE (1) DE69637178D1 (de)
HU (1) HUP9900901A3 (de)
IL (1) IL117874A0 (de)
NO (1) NO974696L (de)
NZ (1) NZ305785A (de)
PL (1) PL322732A1 (de)
RU (1) RU2170577C2 (de)
SK (1) SK138397A3 (de)
TR (2) TR199801216T2 (de)
TW (1) TW422685B (de)
WO (1) WO1996032104A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
AU714056B2 (en) 1995-04-12 1999-12-16 Uaf Technologies And Research Llc A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6225307B1 (en) * 1999-03-31 2001-05-01 The Procter & Gamble Company Viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734911A (en) * 1956-02-14 Reaction of chloroaniline and isopropyl
US2695225A (en) * 1954-05-21 1954-11-23 Columbia Southern Chem Corp Herbicidal compositions
US2806051A (en) * 1955-11-01 1957-09-10 Goodrich Co B F Method for preparing urethanes by reacting urea, amines and an alcohol
US3799758A (en) * 1971-08-09 1974-03-26 Monsanto Co N-phosphonomethyl-glycine phytotoxicant compositions
US3853530A (en) * 1971-03-10 1974-12-10 Monsanto Co Regulating plants with n-phosphonomethylglycine and derivatives thereof
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (de) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Äthylenglykolderivate, ihre Herstellung und Verwendung
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
AU714056B2 (en) 1995-04-12 1999-12-16 Uaf Technologies And Research Llc A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
US5656615A (en) 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
US5629341A (en) * 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers

Also Published As

Publication number Publication date
EP0820281B1 (de) 2007-07-25
NO974696D0 (no) 1997-10-10
US6251870B1 (en) 2001-06-26
TW422685B (en) 2001-02-21
CA2217953A1 (en) 1996-10-17
IL117874A0 (en) 1996-08-04
CN1181701A (zh) 1998-05-13
NO974696L (no) 1997-12-12
PL322732A1 (en) 1998-02-16
BR9604973A (pt) 1998-06-09
AU5389896A (en) 1996-10-30
KR19980703829A (ko) 1998-12-05
WO1996032104A1 (en) 1996-10-17
NZ305785A (en) 2001-10-26
RU2170577C2 (ru) 2001-07-20
AU714056B2 (en) 1999-12-16
US5932604A (en) 1999-08-03
CA2217953C (en) 2001-12-04
HUP9900901A3 (en) 1999-11-29
EP0820281A1 (de) 1998-01-28
CZ323597A3 (cs) 1998-03-18
JPH11503460A (ja) 1999-03-26
TR199801216T2 (xx) 1998-09-21
DE69637178D1 (de) 2007-09-06
SK138397A3 (en) 1998-05-06
HUP9900901A2 (hu) 1999-08-30
TR199701151T1 (xx) 1998-03-21
US5932609A (en) 1999-08-03

Similar Documents

Publication Publication Date Title
ATE367808T1 (de) N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
HUP0100272A2 (hu) Egy aldózreduktáz-gátló és egy glikogénfoszforiláz-gátló együttes alkalmazása
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
BG101118A (en) Therapeutical compounds
NO982310L (no) Protegriner
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
DE69432984D1 (de) Therapeutische substituierte guanidine
HUP9903420A3 (en) Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections
HUP9903506A2 (hu) Grizeofulvin felhasználása rákok növekedésének gátlására
AR002987A1 (es) Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
FI961380A (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
AP9801286A0 (en) Therapeutic compounds.
HUP9700661A2 (hu) Alfa1-adrenoreceptor antagonisták felhasználása rák megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
ATE344664T1 (de) Verbesserte methode zur eradikation von helicobacter pylori
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
FR2699820B3 (fr) Traitement homéopathique préventif des dysmytoses (cancer, leucémie) et malformations ou mutations génétiques.
MX9707810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimiento de virus y canceres.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties